These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9655161

  • 1. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
    Posthuma N, ter Wee PM, Donker AJ, Oe PL, van Dorp W, Peers EM, Verbrugh HA.
    Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA.
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [Abstract] [Full Text] [Related]

  • 3. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years.
    Posthuma N, Verbrugh HA, Donker AJ, van Dorp W, Dekker HA, Peers EM, Oe PL, ter Wee PM.
    Perit Dial Int; 2000; 20(2):174-80. PubMed ID: 10809240
    [Abstract] [Full Text] [Related]

  • 4. Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations.
    Posthuma N, ter Weel PM, Donker AJ, Peers EM, Oe PL, Verbrugh HA.
    Nephrol Dial Transplant; 1998 Sep; 13(9):2341-4. PubMed ID: 9761519
    [Abstract] [Full Text] [Related]

  • 5. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.
    Posthuma N, ter Wee P, Donker AJ, Dekker HA, Oe PL, Verbrugh HA.
    Perit Dial Int; 1999 Sep; 19(4):334-42. PubMed ID: 10507814
    [Abstract] [Full Text] [Related]

  • 6. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
    Gokal R, Mistry CD, Peers EM.
    Perit Dial Int; 1995 Sep; 15(6):226-30. PubMed ID: 7578498
    [Abstract] [Full Text] [Related]

  • 7. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
    Ota K, Akiba T, Nakao T, Nakayama M, Maeba T, Park MS, Tranaeus A, Yorioka N, Icodextrin Study Group.
    Perit Dial Int; 2003 Sep; 23(4):356-61. PubMed ID: 12968843
    [Abstract] [Full Text] [Related]

  • 8. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
    de Waart DR, Zweers MM, Struijk DG, Krediet RT.
    Perit Dial Int; 2001 Sep; 21(3):269-74. PubMed ID: 11475342
    [Abstract] [Full Text] [Related]

  • 9. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S, Racek J, Stehlík P, Senft V, Sefrna F, Topolcan O, Opatrný K.
    Cas Lek Cesk; 2002 May 10; 141(9):281-5. PubMed ID: 12061197
    [Abstract] [Full Text] [Related]

  • 10. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
    Mistry CD, Gokal R, Peers E.
    Kidney Int; 1994 Aug 10; 46(2):496-503. PubMed ID: 7967363
    [Abstract] [Full Text] [Related]

  • 11. [Clinical experience with icodextrin. Multicenter study].
    Guerrero A, Montes R, Martín-Herrera C, Ruiz A, Remón C, Fernández-Ruiz EJ, Pérez-Bañasco V, Benítez M, Martínez-Benavides E, Martínez-González JM, Torán D, Tejuca F, Páez C, del Pino MD.
    Nefrologia; 2001 Aug 10; 21(6):574-80. PubMed ID: 11881427
    [Abstract] [Full Text] [Related]

  • 12. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance.
    Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, Donker AJ.
    Nephrol Dial Transplant; 1997 Mar 10; 12(3):550-3. PubMed ID: 9075139
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, Reynolds R, Ogrinc F, Martis L, Wolfson M.
    Kidney Int Suppl; 2002 Oct 10; (81):S23-33. PubMed ID: 12230479
    [Abstract] [Full Text] [Related]

  • 14. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.
    Davison SN, Jhangri GS, Jindal K, Pannu N.
    Clin J Am Soc Nephrol; 2009 Jun 10; 4(6):1044-50. PubMed ID: 19406971
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, Peeters J, Freida P, Struijk DG, Krediet RT, Grabensee B, Tranaeus A, Filho JC.
    Am J Kidney Dis; 2002 Apr 10; 39(4):862-71. PubMed ID: 11920355
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.
    van Hoeck KJ, Rusthoven E, Vermeylen L, Vandesompel A, Marescau B, Lilien M, Schroder CH.
    Nephrol Dial Transplant; 2003 Jul 10; 18(7):1383-7. PubMed ID: 12808177
    [Abstract] [Full Text] [Related]

  • 20. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE, Plosker GL.
    Drugs; 2003 Jul 10; 63(19):2079-105. PubMed ID: 12962523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.